By Daniella Parra Kohl’s Corporation (NYSE: KSS) said net sales fell 9.4% and 7.2% for both fourth-quarter and fiscal year 2024. The company’s diluted EPS for the fourth quarter was $0.43 ($0.95 adjusted), while full-year diluted EPS was $0.98 ($1.50...

By Karen Roman The ONE Group Hospitality, Inc. (Nasdaq: STKS) said fourth quarter revenue increased 146.7% to $221.9 million from $89.9 million and operating income rose 158.9% to $12.8 million from $4.9 million. The company opened six new restaurants in...

By Daniella Parra Potbelly Corp. (Nasdaq: PBPB) said its average weekly sales increased 1.1% to $25,230 and company-operated same-store sales in the fourth quarter increased 0.3%. Total revenues decreased 7.3% while adjusted EBITDA increased 30.0% to $9.7 million, they said....

By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA) said fourth quarter net sales increased 6.8% to $159 million, compared to $148.9 million the year prior. Adjusted EBITDA was $6.2 million, or 3.9% of net sales, in contrast to $1.3...

By Daniella Parra Ascentage Pharma (NASDAQ: AAPG; HKEX) said that its drug Olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, and has been approved for certain chronic myeloid leukemia (CML) indications and included in China’s National Reimbursement Drug List. Olverembatinib,...

Muslim Pro CEO Nafees Khundker says, “[Our] vision [is] to be the digital home for all things Muslim.” By Exec Edge Editorial Staff By leveraging emerging technology, the Muslim Pro app — which was created to provide daily prayer times...

By Karen Roman Medical tech company Nano-X Imaging Ltd. (Nasdaq: NNOX) said Nanox.ARC, its digital multi-source 3D tomosynthesis imaging system, received CE mark certification in the European market. Nanox.ARC also has FDA clearance for general use in the U.S. and...

By Karen Roman On Holding AG (NYSE: ONON) said fourth quarter adjusted diluted earnings per share increased to CHF 0.33 from CHF (0.05) the year prior, surpassing analysts’ expectations and raising its market price per share around 5%. Gross profit...

Visit Exec Edge Research for Full Report By Rayk Riechmann From banks to hedge funds to mom-and-pop investors, the Bitcoin (BTC) boom has garnered support from virtually every direction, with President Donald Trump this week vowing to create a strategic...

By Daniella Parra Jeito Capital said it invested in Callio Therapeutics’ $187M Series A round to support its next-generation multi-payload antibody-drug conjugates (ADCs) for cancer treatment. Callio Therapeutics is a biotechnology company developing multi-payload ADCs that says it aims to...